Zdenek Kleibl
Institute of Biochemistry and Experimental Oncology
First Faculty of Medicine
Charles University in Prague
U Nemocnice 5
Czech Republic
Name/email consistency: medium
- The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development. Kleibl, Z., Havranek, O., Kormunda, S., Novotny, J., Foretova, L., Machackova, E., Soukupova, J., Janatova, M., Tavandzis, S., Pohlreich, P. J. Cancer Res. Clin. Oncol. (2011)
- The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population. Kleibl, Z., Havranek, O., Hlavata, I., Novotny, J., Sevcik, J., Pohlreich, P., Soucek, P. Eur. J. Cancer (2009)
- Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy. Kleibl, Z., Fidlerova, J., Kleiblova, P., Kormunda, S., Bilek, M., Bouskova, K., Sevcik, J., Novotny, J. Neoplasma (2009)
- Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations. Kleibl, Z., Havranek, O., Novotny, J., Kleiblova, P., Soucek, P., Pohlreich, P. Breast Cancer Res. Treat. (2008)
- The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Kleibl, Z., Novotny, J., Bezdickova, D., Malik, R., Kleiblova, P., Foretova, L., Petruzelka, L., Ilencikova, D., Cinek, P., Pohlreich, P. Breast Cancer Res. Treat. (2005)
